ID: ALA473587

Max Phase: Preclinical

Molecular Formula: C11H16FN2O9P

Molecular Weight: 370.23

Molecule Type: Small molecule

Associated Items:

Representations

Canonical SMILES:  CCc1c(F)c(=O)[nH]c(=O)n1[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O

Standard InChI:  InChI=1S/C11H16FN2O9P/c1-2-4-6(12)9(17)13-11(18)14(4)10-8(16)7(15)5(23-10)3-22-24(19,20)21/h5,7-8,10,15-16H,2-3H2,1H3,(H,13,17,18)(H2,19,20,21)/t5-,7-,8-,10-/m1/s1

Standard InChI Key:  JBBLQWFDKGRNST-VPCXQMTMSA-N

Associated Targets(Human)

Uridine 5'-monophosphate synthase 20 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

Orotidine 5'-phosphate decarboxylase 39 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 370.23Molecular Weight (Monoisotopic): 370.0577AlogP: -2.03#Rotatable Bonds: 5
Polar Surface Area: 171.31Molecular Species: ACIDHBA: 8HBD: 5
#RO5 Violations: 0HBA (Lipinski): 11HBD (Lipinski): 5#RO5 Violations (Lipinski): 1
CX Acidic pKa: 1.23CX Basic pKa: CX LogP: -1.61CX LogD: -5.19
Aromatic Rings: 1Heavy Atoms: 24QED Weighted: 0.37Np Likeness Score: 0.55

References

1. Bello AM, Konforte D, Poduch E, Furlonger C, Wei L, Liu Y, Lewis M, Pai EF, Paige CJ, Kotra LP..  (2009)  Structure-activity relationships of orotidine-5'-monophosphate decarboxylase inhibitors as anticancer agents.,  52  (6): [PMID:19260677] [10.1021/jm801224t]

Source